Top 5 Health Care Startup Investors in Latvia (May 2026)

FlyCap AIF is a Venture Capital Fund of total size of 15.75 MEUR. The Fund provides growth capital for Latvia based SME’s in a form of investments in equity and mezzanine capital.

Investment focus

Industry: Health Care, Consumer Goods, Medical
Stage:Seed, Debt Financing
Geography: Latvia, Estonia, The Netherlands

Investor stats

Total investments: 29
Round size: Seed $54k–$2.8M
Lead/follow: 38% lead, 62% follow
Last fund: May invest from a new fund soon — raised $17M in 2013

Portfolio highlights

Tapcore — Tapcore is the only solution on the market that enables mobile developers to monetize pirated copies of their apps through advertising. Established in 2015, we are a remote company with headquarters in the Netherlands. Currently we serve over 150 million ad requests daily (and counting!).
Purified — Purified is a nutritional supplement supplier.. It offers black chocolate produced by the best doctors in collaboration with scientists.
Elmo — In our car sharing business Elmo Rent we wanted to serve maximum customers with minimum resources, so we created remote control technology to deliver vehicles.

Show all investments...

We are Abingworth, a trans-atlantic bio-science investment firm with a deep understanding of both the science and markets we invest in.

Investment focus

Industry: Biotechnology, Health Care, Pharmaceutical
Stage:Series B, Series A, Series C
Geography: United States, United Kingdom, Switzerland

Investor stats

Total investments: 152
Round size: Series A $14M–$45M; Series B $14M–$60M; Series C $14M–$150M
Lead/follow: 29% lead, 71% follow
Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

Iambic Therapeutics — Iambic has created a cutting-edge AI-driven platform to tackle the most challenging design problems in drug discovery and address unmet patient need.
Ascend Gene & Cell Therapies — Ascend Gene & Cell Therapies supports manufacturing and process development projects from design through to clinical and commercial scales. They partner with biotechnology teams to embed scalable manufacturing in their operations from the beginning. They respond to customer inquiries by phone and contact form.
Spruce Biosciences — Developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need

Show all investments...

ZGI Capital is the fund management company that manages "ZGI fund”, that was founded to support entrepreneurs lacking start-up capital for their business. The total amount of assets available for venture capital investments is of EUR 7.4M. Combined with bank financing, this will allow to finance investment projects with total assets of up toEUR 30M. The fund acts on behalf of various investors including the State.

Investment focus

Industry: Manufacturing, Machinery Manufacturing, Consulting
Stage:Seed, Debt Financing
Geography: Latvia, Estonia

Investor stats

Total investments: 25
Round size: Seed $54k–$875k; Debt Financing $107k–$959k
Lead/follow: 92% lead, 8% follow
Last fund: May invest from a new fund soon — last raise in 2017

Portfolio highlights

eAgronom — eAgronom helps farmers generate additional revenue streams, improve soil quality, and access better financing.
KOOL Latvija — "KOOL Latvija" is a new concept gas station created in Latvia, which at the same time is also a convenient fast shopping place.
Bioreactors.net — Biotechnical center is an innovative company and we provide solutions for industrial biotechnology processes, bioreactor manufacturing and industrial automation. We manufacture bioreactors for laboratory, pilot and industrial scale.

Show all investments...

Qiming Venture Partners invests in young, fast-growing companies across China in the media and internet, IT, consumer and retail, healthcare, and clean technology sectors. we are early to growth stage venture capital firm with offices in Shanghai, Beijing and Hong Kong. Since their debut in 2006, we have established their selves as a leadinginvestment firm in China and currently manage four funds with over $1 billion in assets.

Investment focus

Industry: Biotechnology, Health Care, Pharmaceutical
Stage:Series A, Series B, Seed
Geography: United States, China, Latvia

Investor stats

Total investments: 26
Round size: Series A $14M–$51M; Series B $36M–$115M
Lead/follow: 21% lead, 79% follow

Portfolio highlights

Entact Bio — Entact Bio is a biotechnology company that is in the preclinical stages of developing medications to improve protein function. It was founded by a team with deep roots in deubiquitinase (DUB) biochemistry, chemical biology, disease biology, and small-molecule drug development. The company's proprietary EncompassTM platform was designed tocreate enhancement-targeting chimeric (ENTACTM) medicines. ENTACs take advantage of DUBs' ability to regulate proteins.
Soda Health — We are a healthcare technology company dedicated to eliminating health inequities through social determinants of health. Our services include supplemental benefit administration, highly customizable member benefit programs with restricted spending and multi-balance capabilities, and robust member data analytics with benefit design recommendations.
Tenpoint Therapeutics — Tenpoint Therapeutics is a biotechnology company pursuing vision-restoring engineered cell-based therapeutics.

Show all investments...